Cointime

Oxagen

company

About

Oxagen is a biopharmaceutical company developing small molecule drugs addressing asthma, and chronic allergic and inflammatory conditions.

  • 51 - 100

Highlights

Total Funding Amount
£30M
Funding Rounds
1
Investors
4

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
£30M
Industries
Biopharma,Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 1997
Number Of Employee
51 - 100
Operating Status
Active

Oxagen Limited, a biopharmaceutical company, provides drug discovery and development solutions. It offers molecule drugs for the treatment of asthma, autoimmune disease, inflammatory bowel, psoriasis, allergy, and rheumatoid arthritis diseases. Oxagen Limited was founded in 1997 and is based in Abingdon, the United Kingdom.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
£30M
Oxagen has raised a total of £30M in funding over 2 rounds. Their latest funding was raised on Dec 21, 2000 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 21, 2000 Series Unknown £30M 4 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
4
Oxagen is funded by 4 investors. Invesco and 3i Plc are the most recent investors.
Investor Name Lead Investor Funding Round
Invesco — Series Unknown
3i Plc — Series Unknown
BankInvest Biomedical Venture — Series Unknown
Pacific Rim Ventures — Series Unknown
Cointime
Содержание
компания